Biofarm S.A. (BVB:BIO)

Romania · Delayed Price · Currency is RON

1.325

-0.015 (-1.12%)

At close: Aug 12, 2026

49.89% (1Y)

Market Cap	1.32B +50.6%
Revenue (ttm)	316.75M +2.1%
Net Income	100.84M +17.1%
EPS	0.09 +16.2%
Shares Out	985.37M
PE Ratio	14.52
Forward PE	n/a
Dividend	0.04 (3.13%)
Ex-Dividend Date	Jun 29, 2026

Volume	14,774
Open	1.340
Previous Close	1.340
Day's Range	1.325 - 1.340
52-Week Range	0.782 - 1.495
Beta	0.51
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Biofarm

Biofarm S.A. manufactures pharmaceutical products. The company's products include cardiovascular, digestive and metabolic, genito-urinary, ophthalmological, endocrine, nervous system, osteo-muscular, respiratory and ENT, multivitamin, antiallergen, and dermatological products. Biofarm S.A. was founded in 1921 and is based in Bucharest, Romania. As of June 24, 2026, Biofarm S.A. operates as a subsidiary of Polpharma SA Pharmaceutical Works. [Read more]

Industry Pharmaceutical Preparations

Founded 1921

Employees 374

Stock Exchange Bucharest Stock Exchange

Ticker Symbol BIO

Full Company Profile

Financial Performance

In 2025, Biofarm's revenue was 319.33 million, an increase of 11.36% compared to the previous year's 286.77 million. Earnings were 100.63 million, an increase of 35.27%.

Financial Statements